Vokes EE - Search Results

1

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.

Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE. Argiris A, et al. Among authors: vokes ee. Head Neck. 2004 May;26(5):447-55. doi: 10.1002/hed.10394. Head Neck. 2004. PMID: 15122662

2

Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.

Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A, Dunphy E, Mick R, Yandell D, Weichselbaum RR. Brachman DG, et al. Cancer Res. 1992 Sep 1;52(17):4832-6. Cancer Res. 1992. PMID: 1324797

3

Evaluation of homoharringtonine efficacy in the treatment of squamous cell carcinoma of the head and neck: a phase II Illinois Cancer Council Study.

Runge-Morris MA, Kies MS, Vokes E, Blough R, Weidner L, Knop R, Rowland K. Runge-Morris MA, et al. Invest New Drugs. 1989 Jul;7(2-3):269-73. doi: 10.1007/BF00170872. Invest New Drugs. 1989. PMID: 2793384

4

Surgical management of the head and neck cancer patient following concomitant multimodality therapy.

Panje WR, Namon AJ, Vokes E, Haraf DJ, Weichselbaum RR. Panje WR, et al. Laryngoscope. 1995 Jan;105(1):97-101. doi: 10.1288/00005537-199501000-00021. Laryngoscope. 1995. PMID: 7837923

5

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer.

Taylor SG 4th, Murthy AK, Vannetzel JM, Colin P, Dray M, Caldarelli DD, Shott S, Vokes E, Showel JL, Hutchinson JC, et al. Taylor SG 4th, et al. J Clin Oncol. 1994 Feb;12(2):385-95. doi: 10.1200/JCO.1994.12.2.385. J Clin Oncol. 1994. PMID: 8113846 Clinical Trial.

6

p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.

Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR. Brachman DG, et al. Cancer Res. 1993 Aug 15;53(16):3667-9. Cancer Res. 1993. PMID: 8339273

7

The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity.

List MA, D'Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E. List MA, et al. Cancer. 1996 Jun 1;77(11):2294-301. doi: 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S. Cancer. 1996. PMID: 8635098

8

Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer.

List MA, Mumby P, Haraf D, Siston A, Mick R, MacCracken E, Vokes E. List MA, et al. Qual Life Res. 1997 Apr;6(3):274-84. doi: 10.1023/a:1026419023481. Qual Life Res. 1997. PMID: 9226985

9

Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer.

Lad T, Rosen F, Sciortino D, Brockstein B, Keubler JP, Arietta R, Vokes E. Lad T, et al. Invest New Drugs. 2000 Aug;18(3):261-3. doi: 10.1023/a:1006481924287. Invest New Drugs. 2000. PMID: 10958595 Clinical Trial.

10

An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neck.

List MA, Lee Rutherford J, Stracks J, Haraf D, Kies MS, Vokes EE. List MA, et al. Among authors: vokes ee. Cancer. 2002 Jul 1;95(1):98-104. doi: 10.1002/cncr.10653. Cancer. 2002. PMID: 12115322 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters